Proteomics reveals protein profile changes in doxorubicin – treated MCF-7 human breast cancer cells
- 5 February 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 181 (1) , 95-107
- https://doi.org/10.1016/s0304-3835(02)00025-3
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001
- Proteasome-Dependent Degradation of Cytosolic Chaperonin CCTBiochemical and Biophysical Research Communications, 2000
- Changes in the phosphorylation status of the 27 kDa heat shock protein (HSP27) associated with the modulation of growth and/or differentiation in MCF-7 cellsCell Proliferation, 1997
- Rapid Protein Identification Using N-Terminal “Sequence Tag” and Amino Acid AnalysisBiochemical and Biophysical Research Communications, 1996
- HSP70 Overexpression Mediates the Escape of a Doxorubicin-Induced G2 Cell Cycle ArrestBiochemical and Biophysical Research Communications, 1996
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Biological differences among MCF-7 human breast cancer cell lines from different laboratoriesBreast Cancer Research and Treatment, 1987
- Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agentsBiochemical and Biophysical Research Communications, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970